CLEMENTI, EMILIO GIUSEPPE IGNAZIO
CLEMENTI, EMILIO GIUSEPPE IGNAZIO
Dipartimento di Scienze Biomediche e Cliniche
From the Scientific Underground to the Height of Recognition: The 40th Anniversary of Rita Levi-Montalcini’s Nobel Prize and the Promising Horizon in Psychiatry
2026 L. Junkes, A.E. Nardi, E. Clementi
Secretory Acid Sphingomyelinase in Children and Adolescents With Type 1 Diabetes
2026 C. Mameli, A. Bolchini, C. Ferrigno, P.M. Roux, A. Arcari, S. Zecchini, A. Napoli, F.C. Redaelli, M. Macedoni, A. Petitti, G. Zuccotti, E. Clementi, C. Perrotta
Fever in a palliative care setting: Clinical insights and implications from a prospective observational cohort study
2026 S. Cheli, E. Angeli, O. Corli, S. Dinegro, A. Zambelli, T. Carta, R. Shazivari, M. Smolikova, P. Franceschi, F. Molà, Y.S. Cruzeiro, E. Clementi, A. Gori
Effects of Fluoxetine on Cognitive Functioning in Children with Down Syndrome: A Prospective Open-Label Exploratory Study of Safety and Efficacy
2026 I. Scala, C. Bravaccio, M. Marino, O. Scicolone, V. Maffettone, M.P. Riccio, G. Terrone, D. Cattaneo, E. Clementi, R. Bartesaghi, P. Strisciuglio
Immunosenescence in skeletal muscle: The role-play in cancer cachexia chessboard
2025 M. Giovarelli, E. Mocciaro, C. Carnovale, D. Cervia, C. Perrotta, E. Clementi
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy
2025 C. Perrotta, C. Carnovale, M. Pozzi, C. De Palma, D. Cervia, M. Nobile, E. Clementi
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
2025 M. Schiuma, S. Dinegro, V. Battini, A. Torre, A. Covizzi, A. Civati, M. Galimberti, I. Mariani, G. Mosini, C. Carnovale, A. Riva, A. Gori, S. Antinori, E. Clementi, S. Radice, S. Cheli
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery
2025 M. Giovarelli, S. Zecchini, S.R. Casati, L. Lociuro, O. Gjana, L. Mollica, E. Pisanu, H.D. Mbissam, O. Cappellari, C. De Santis, A. Arcari, A. Bigot, G. Clerici, E. Catalani, S. Del Quondam, A. Andolfo, C. Braccia, M.G. Cattaneo, C. Banfi, D. Brunetti, E. Mocciaro, A. De Luca, E. Clementi, D. Cervia, C. Perrotta, C. De Palma
Low-dose aspirin and risk of anaemia in older adults: insights from a Danish register-based cohort study
2024 M.A. Barbieri, D.S. Peker, M.G.S. Askar, V. Battini, A. Abate, C. Carnovale, E. Clementi, R. Ofori-Asenso, E. Spina, M. Pareek, K. Kragholm, C. Torp-Pedersen, M. Sessa
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study
2024 S. Cheli, A. Torre, M. Schiuma, C. Montrasio, A. Civati, M. Galimberti, V. Battini, I. Mariani, G. Mosini, C. Carnovale, S. Radice, E. Clementi, A. Gori, S. Antinori
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling
2024 D. Cervia, S. Zecchini, L. Pincigher, P. Roux-Biejat, C. Zalambani, E. Catalani, A. Arcari, S. Del Quondam, K. Brunetti, R. Ottria, S. Casati, C. Vanetti, M.C. Barbalace, C. Prata, M. Malaguti, S.R. Casati, L. Lociuro, M. Giovarelli, E. Mocciaro, S. Falcone, C. Fenizia, C. Moscheni, S. Hrelia, C. De Palma, E. Clementi, C. Perrotta
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
2024 V. Battini, M.A. Barbieri, C. Carnovale, E. Spina, E. Clementi, M. Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
2024 M. Cocco, C. Carnovale, E. Clementi, M.A. Barbieri, V. Battini, M. Sessa
PPP exposure models for 3‐D orchards considering spraying technologies in Southern Europe
2024 G. Azimonti, P.C. Adell, E. Clementi, K.P. Ferentinos, C.G. Figueroa, M. Grella, M. Luini, P. Marucco, E. Mozzanini, M. Resecco, L. Tosti
New data-driven method to predict the therapeutic indication of redeemed prescriptions in secondary data sources: a case study on antiseizure medications users aged ≥65 identified in Danish registries
2024 I. Mahmoud, V. Battini, C. Carnovale, E. Clementi, K. Kragholm, M. Sessa
Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology
2024 A. Colombo, R. Cafaro, I. Di Bernardo, M. Mereghetti, L. Cerolini, L. Giacovelli, F. Giorgetti, S. Vanzetto, N. Girone, V. Savasi, I. Cetin, E. Clementi, M.F. Bosi, V. Caterina, B. Dell’Osso
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure
2024 V. Battini, M. Cocco, M.A. Barbieri, G. Powell, C. Carnovale, E. Clementi, A. Bate, M. Sessa
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
Exposure to environmental pollutants and attention-deficit/hyperactivity disorder: an overview of systematic reviews and meta-analyses
2023 E. Rosi, A. Crippa, M. Pozzi, S. De Francesco, M. Fioravanti, M. Mauri, M. Molteni, L. Morello, L. Tosti, F. Metruccio, E. Clementi, M. Nobile
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
2023 C. Perrotta, C. Fenizia, C. Carnovale, M. Pozzi, D. Trabattoni, D. Cervia, E. Clementi